Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

Go back to Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

Repligen (RGEN) Tops Q3 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus

October 31, 2019 7:39 AM EDT

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.26, $0.07 better than the analyst estimate of $0.19. Revenue for the quarter came in at $69.4 million versus the consensus estimate of $66.1 million.

Third Quarter 2019 Highlights

Revenue increased by 40% year-over-year as reported (42% at constant currency) and 28% organically, to $69.4 millionGAAP fully diluted EPS decreased to $0.03 compared to $0.10 for the third quarter of 2018Adjusted (non-GAAP) fully diluted EPS increased to $0.26 compared to $0.18 for the third quarter of 2018

REVENUE

Total revenue for the third quarter of 2019 increased to $69.4 million compared to $49.5 million for the third quarter of... More